{"filings":[{"id":2162203,"accession_number":"0001104659-26-093349","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-08-10T20:05:49+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Teledyne to acquire Varex Imaging for $18.90/share in cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Deal: $18.90/share cash; expected close early 2027, subject to stockholder and regulatory approvals (HSR, foreign).","Termination fee: $25.3M payable by Varex under certain conditions; no financing condition.","Equity awards: named executives get cash payouts: Sanyal $8.70M, Maheshwari $2.77M, Hartmann $1.45M, Jonaitis $1.45M.","Special meeting to be held; proxy statement to be filed within 30 days.","Shares to be delisted from Nasdaq after close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2144439,"accession_number":"0001104659-26-093036","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-08-10T11:32:16+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 FY26 revenue $211M, up 4% YoY; non-GAAP EPS $0.31 vs $0.13","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $211M, up 4% YoY; Medical $134M, Industrial $77M; non-GAAP EPS $0.31 vs $0.13 prior year.","Received $17M U.S. Customs refunds for IEEPA tariffs; recorded $7M revenue reduction for customer reimbursements, boosting gross profit ~$10M.","Non-GAAP gross margin improved to 37% from 34% YoY; operating cash flow $21M.","Cash and marketable securities $99M vs $155M at FY25 end, reflecting March debt redemption/refinancing and inventory working capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":94662,"accession_number":"0001681622-26-000051","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $216M (+1% YoY), GAAP EPS -$0.19; guides FY26 rev $860-880M, non-GAAP EPS $0.80-1.00","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $216M (+1% YoY); Medical $156M, Industrial $60M.","GAAP net loss $0.19/diluted share; Non-GAAP net income $0.21/diluted share.","Non-GAAP gross margin 34% (down from 36% YoY); cash outflows ops $2M; cash $88M (down from $155M).","FY26 guidance: revenue $860-880M, non-GAAP EPS $0.80-1.00; Q3FY26 rev $210-225M, non-GAAP EPS $0.15-0.30.","CEO cites momentum in CT, cargo, photon counting detectors; tariff refunds not assumed in guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":425600000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107193,"accession_number":"0001681622-26-000035","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $490M credit facility, redeems $368M 7.875% notes due 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New facility includes $350M term loan, $100M revolver, $40M delayed draw; matures March 13, 2031.","Redeemed all $368M of 7.875% Senior Secured Notes due 2027; used $42M cash including $7M call premium.","Borrowings at SOFR + 2.50% margin (3.65% fixed via swap); expected to reduce annualized interest by >$7M.","Terminated existing $155M revolver; no outstanding borrowings at termination.","CFO Maheshwari says refinancing strengthens balance sheet and improves cost of capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107192,"accession_number":"0001681622-26-000031","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Varex Imaging shareholders elect all seven director nominees at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with >34M votes for each; broker non-votes ~3.4M.","Advisory say-on-pay approved: 33,985,913 for, 1,004,141 against, 167,107 abstain.","Ratification of Deloitte & Touche as auditor for FY2026: 38,106,353 for, 301,360 against.","Meeting had ~92% of outstanding shares represented (38,575,226 shares) forming a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107191,"accession_number":"0001681622-26-000015","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 revenue $210M (+5% YoY), Non-GAAP EPS $0.19, guides Q2 rev $210-225M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $0.05 per diluted share; Non-GAAP EPS $0.19 (up from $0.10 YoY).","Medical segment revenue $145M; Industrial segment $65M (+17% YoY on cargo systems strength).","Cash outflow from operations $16M; cash & equivalents $126M (down from $155M).","Q2 FY2026 guidance: revenue $210-225M, Non-GAAP EPS $0.15-0.25.","Results at high-end of guidance; demand for CT and cargo security remains strong."],"consensus_eps_estimate":null,"consensus_eps_actual":0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":209600000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123527,"accession_number":"0001681622-25-000106","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q4 revenue $229M (+11% YoY); Non-GAAP EPS $0.37; guides Q1 $200-215M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY25 revenue $229M, up 11% YoY; Medical segment $152M (+5%), Industrial $77M (+25%).","GAAP diluted EPS $0.29; Non-GAAP diluted EPS $0.37, up from $0.19 in Q4 FY24.","FY25 revenue $845M (+4% YoY); Non-GAAP EPS $0.90 (+73%); Non-GAAP EBITDA $122M (+37%).","Cash & securities $155M at FY25 end, down from $213M due to convertible debt paydown in June 2025.","Q1 FY26 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.25."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":844600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140205,"accession_number":"0001681622-25-000090","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Varex SVP & CLO Kimberley Honeysett to transition; advisory role through Dec 2027","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kimberley Honeysett steps down as CLO effective Oct 3, 2025, then remains as non-executive employee/advisor until Dec 12, 2027.","During FY2026 she receives current salary and bonus eligibility; thereafter $100,000/year plus health benefits.","Outstanding equity awards continue to vest through the Continued Service Period; no new equity grants.","Company may terminate with Cause; Transition Agreement includes mutual general releases and indemnification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":140204,"accession_number":"0001681622-25-000083","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 revenue $203M beats guidance; GAAP loss $(2.15), non-GAAP profit $0.18","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue of $203M down 3% YoY but above high-end guidance; Industrial segment up 1% to $61M, Medical down 4% to $142M.","GAAP net loss of $(2.15) per diluted share; non-GAAP net earnings of $0.18 per diluted share, up from $0.14 YoY.","Cash flow from operations $8M; cash and securities $153M down from $226M prior quarter due to Convertible Notes paydown.","Q4 FY2025 guidance: revenue $210M-$230M, non-GAAP EPS $0.10-$0.30.","CEO expects fiscal 2025 sales growth of ~3%, citing strong cargo inspection and healthy demand in both segments."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":615700000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157851,"accession_number":"0001681622-25-000061","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $213M (+3% YoY); China tariff pause cuts Q3 outlook to $180-200M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $0.17, Non-GAAP EPS $0.26 vs $0.16 prior year.","Medical segment revenue $154M (+3% YoY); Industrial $59M (+3% YoY).","Cash flow from operations $17M; cash equivalents $226M excluding $125M restricted.","Plans to repay outstanding Convertible Notes due June 2025 upon maturity.","Q3 guidance: revenue $180-200M with China ~$10M; Non-GAAP EPS -$0.05 to $0.10."],"consensus_eps_estimate":0.0357,"consensus_eps_actual":0.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":412700000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":157850,"accession_number":"0001681622-25-000050","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"China MOFCOM launches anti-dumping probe on CT X-ray tubes; Varex could be impacted","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["China MOFCOM announced anti-dumping investigation into medical CT X-ray tubes from US and India.","Varex produces tubes in the US and ships to China; does not produce in India.","Company has not received formal notice; believes it complies with competition laws.","Varex states it will cooperate should it receive formal notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176233,"accession_number":"0001681622-25-000018","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-02-14T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Varex stockholders approve officer exculpation amendment; re-elect all directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected with 34.2M to 35.0M votes for; brokers non-voted 2.6M shares.","Advisory say-on-pay resolution passed: 34.2M for, 1.0M against, 2.6M broker non-votes.","Advisory frequency of say-on-pay set at one year: 33.1M for one year, 2.1M for three years.","Officer exculpation amendment to Certificate of Incorporation approved: 28.8M for, 6.5M against.","Ratification of Deloitte & Touche as independent auditor for FY2025: 37.7M for, 0.2M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176232,"accession_number":"0001681622-25-000013","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).","Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.","Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.","Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.","CEO cited solid demand and favorable sales mix driving higher-than-expected profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":199800000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":176231,"accession_number":"0001681622-25-000003","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K/A","filed_at":"2025-01-06T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Varex terminates $20M equipment credit facility after senior secured notes offering","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Equipment Credit Agreement with Zions terminated effective Dec 20, 2024, confirmed Jan 3, 2025.","Facility of up to $20M was no longer needed following December 20, 2024 senior secured notes offering.","No amounts were outstanding under the terminated agreement; no early termination penalty incurred.","Original 8-K filed Dec 23, 2024; this amendment supplements Item 1.02 with closure confirmation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193121,"accession_number":"0001681622-24-000119","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $125M 7.875% senior secured notes due 2027 for convertible note repayment","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$125M aggregate principal at 101.5% of par, 7.875% coupon, maturing 2027.","Net proceeds ~$124M to partially repay $200M convertible notes due June 2025.","Additional notes are part of same issue as existing $300M notes ($243M outstanding).","Company to terminate unused $20M equipment credit agreement post-closing.","CFO states offering preserves availability under revolving credit facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193120,"accession_number":"0001681622-24-000104","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-12-17T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Varex prices $125M add'l 7.875% senior secured notes due 2027 to repay convertible notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$125M aggregate principal of 7.875% senior secured notes due Oct 2027 priced at 101.5% of par.","Proceeds to fund partial repayment of outstanding Convertible Notes due June 2025.","Notes are additional issuance under existing indenture; $243M of original $300M notes still outstanding.","Closing expected Dec 20, 2024; Varex also intends to terminate $20M Equipment Credit Agreement.","Notes are senior secured, guaranteed by subsidiaries, with first and second liens on specified assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":193119,"accession_number":"0001681622-24-000088","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q4 FY24 revenue $206M; GAAP EPS loss $1.22, non-GAAP EPS $0.19","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $1.22 per diluted share; non-GAAP EPS of $0.19, down from $0.45 YoY.","Total revenue $206M in Q4 FY24, down 10% YoY; full-year revenue $811M.","Medical segment revenue $144M (-12% YoY); Industrial $61M (-4% YoY).","Ended FY24 with $213M cash and marketable securities; operating cash flow $26M in Q4.","Q1 FY25 guidance: revenue $195-215M, non-GAAP EPS -$0.05 to $0.10."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":811000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209502,"accession_number":"0001681622-24-000083","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Varex amends credit agreement to relax covenants on convertible note payments and leverage","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment dated Sept 11, 2024 with Zions Bancorporation modifies Payment Conditions to allow restricted payments up to greater of 50% of CNI or $50M when leverage >2.50x.","Fixed Charge Coverage Ratio definition now excludes up to $200M in convertible note payments for covenant measurement.","For Q4 FY2024 and Q1/Q2 FY2025, cash deduction for leverage ratio calculation increased from $100M to $150M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":209501,"accession_number":"0001681622-24-000068","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 FY2024 revenue down 10% YoY; Q4 guidance weak","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $209M (-10% YoY); GAAP EPS $0.03, Non-GAAP EPS $0.14 vs $0.37 YoY.","Medical segment revenue $149M (-15% YoY); Industrial segment $60M (+6% YoY).","Cash flow from operations $8M; cash and equivalents $192M (flat vs FY2023).","Q4 FY2024 guidance: revenue $190-210M, Non-GAAP EPS $0.00-$0.15, citing challenging market conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":605300000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227573,"accession_number":"0001681622-24-000058","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 revenue $206M, down 10% YoY; lowers H2 outlook due to China softness","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $206M, down 10% YoY; GAAP EPS $0.03, Non-GAAP EPS $0.16 (down from $0.26).","Medical segment revenue $149M (-15% YoY); Industrial $57M (+6% YoY).","Non-GAAP gross margin 33% flat YoY; operating cash flow $3M.","Q3 guidance: revenue $200-220M, non-GAAP EPS $0.05-$0.25; management lowered H2 expectations.","CEO cited continued softness in China as primary headwind for medical segment."],"consensus_eps_estimate":null,"consensus_eps_actual":0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":396200000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246391,"accession_number":"0001681622-24-000052","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-03-27T23:59:59+00:00","items":["1.01","1.02","2.03","8.01","9.01"],"status":"ready","headline":"Varex closes $155M senior secured revolving credit facility with Zions, replaces prior ABL","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $155M senior secured revolving credit facility matures September 26, 2027.","Interest rate: SOFR + 2.00%-2.75% margin; base rate option; unused fee 0.30%-0.40%.","Proceeds for working capital, general corporate purposes, potential debt repayment.","Collateral: first lien on inventory, AR, cash; second lien on assets securing 7.875% Senior Secured Notes.","Existing ABL credit facility terminated simultaneously with no outstanding balance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246390,"accession_number":"0001681622-24-000014","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-02-09T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Varex Imaging shareholders elect directors, approve amended equity plan at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with ~92% of shares represented; vote results filed.","Advisory vote on executive compensation approved with 33.3M for vs 1.6M against.","Amended 2020 Omnibus Stock Plan approved, adding 5.8M shares authorized for future awards.","Deloitte & Touche ratified as independent auditor for FY2024 with 37.2M for.","Amended plan as of February 9, 2024; restated terms included in Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246389,"accession_number":"0001681622-24-000008","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2024-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 FY2024 revenue $190M (-8% YoY), GAAP loss $0.01/sh, non-GAAP EPS $0.06","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $190M, down 8% YoY; Medical segment $140M (-13%), Industrial $50M (+10%).","GAAP net loss $0.01/diluted share; Non-GAAP EPS $0.06 vs $0.21 in prior year.","Non-GAAP gross margin 31% (vs 32% YoY); operating margins declined.","Cash from operations $10M; cash & equivalents $195M, flat vs FY2023 year-end.","Q2 FY2024 guidance: revenue $195-215M, non-GAAP EPS $0.10-$0.30."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":190000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263826,"accession_number":"0001681622-23-000077","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-11-17T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Varex Imaging adopts form of Performance Unit Agreement for future awards","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Compensation Committee approved a form of Performance Unit Agreement under the 2020 Omnibus Stock Plan on November 17, 2023.","The agreement will be used to evidence performance unit grants but no specific grants were announced.","Standard terms include vesting based on performance goals, forfeiture, clawback, and tax withholding provisions.","No material financial impact is expected from this procedural adoption."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":263825,"accession_number":"0001681622-23-000069","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q4 FY2023 rev $227M; Medical down 10% YoY, Industrial up 27%; guides Q1 FY2024 rev $180-$200M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $227M, down 2% YoY and 2% sequentially; full-year record revenue $893M.","GAAP EPS $0.66 per diluted share; non-GAAP EPS $0.45 per diluted share.","Medical segment revenue down 10% YoY (China anti-corruption headwind); Industrial up 27% YoY.","Cash from operations $47M in Q4; cash & marketable securities $195M at year-end.","Q1 FY2024 guidance: revenue $180-$200M, non-GAAP EPS $0.00-$0.20."],"consensus_eps_estimate":null,"consensus_eps_actual":1.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":893400000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281036,"accession_number":"0001681622-23-000063","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex reports record Q3 revenue of $232M, up 8% YoY; non-GAAP EPS $0.37","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $232M (record), up 8% YoY; Medical segment $175M (+5%), Industrial $57M (+20%).","GAAP EPS $0.21/diluted; non-GAAP EPS $0.37/diluted; non-GAAP gross margin 34% (above expectations).","Cash flow from operations $38M; cash & equivalents up $30M sequentially to $152M.","Q4 FY23 guidance: revenue $220M-$240M, non-GAAP EPS $0.20-$0.40 per diluted share.","CEO cites continued strength in Industrial segment and improved inventory management."],"consensus_eps_estimate":null,"consensus_eps_actual":0.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":666000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":299744,"accession_number":"0001681622-23-000047","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 FY2023 revenue $228M beats guidance; non-GAAP EPS $0.26","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $228M, up 6% YoY and 11% sequentially; GAAP EPS $0.10, non-GAAP EPS $0.26.","Medical segment rev $174M (+2% YoY); Industrial segment rev $54M (+22% YoY).","Cash flow from operations $27M; cash, equivalents, securities $122M, up $14M sequentially.","Q3 FY2023 guidance: revenue $220–$240M, non-GAAP EPS $0.20–$0.40.","Management cites strong demand, exceeded high-end of guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":433800000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319850,"accession_number":"0001681622-23-000016","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-02-13T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Varex elects 7 directors; Walter Rosebrough becomes Board Chair after Naumann-Etienne retirement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with 34M to 34.5M votes for each; over 91% support.","Advisory vote on executive compensation approved: 32.39M for, 2.52M against.","Ratification of Deloitte & Touche as auditor for FY2023 passed (37.07M for).","Walter M Rosebrough Jr. elected Board Chair on Feb 10, succeeding retired Ruediger Naumann-Etienne."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319849,"accession_number":"0001681622-23-000012","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-01-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 revenue $206M, down 11% sequential; Non-GAAP EPS $0.21; Q2 guidance soft","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $206M (-11% QoQ, +3% YoY); Medical $160M, Industrial $46M.","GAAP EPS $0.08; Non-GAAP EPS $0.21 (down from $0.42 prior quarter).","Non-GAAP gross margin 32% vs 33% in Q4 FY22.","Q2 FY23 guidance: revenue $205M-$225M; Non-GAAP EPS $0.05-$0.25.","Operating cash flow -$4M on higher inventory and annual incentive payments."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":205600000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":319848,"accession_number":"0001681622-23-000004","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2023-01-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Varex Imaging SVP/GM Detectors Brian Giambattista to retire; Andrew Hartmann named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian Giambattista retires as SVP & GM Detectors effective March 31, 2023; Andrew Hartmann (SVP Medical Sales & Marketing) succeeds him April 3, 2023.","Giambattista to remain a non-executive employee until February 28, 2025 under Transition Agreement with half salary and continued equity vesting.","Company will conduct a search, internal and external, to fill Hartmann's prior role; Hartmann's compensation unchanged materially.","Transition Agreement includes non-disparagement, non-solicitation, non-competition clauses during Transition and Continued Employment Periods."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":338057,"accession_number":"0001681622-22-000088","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2022-11-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex reports record Q4 revenue of $231M; non-GAAP EPS $0.42, guides Q1 $195-215M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record Q4 revenue $231M (up 8% seq., 2% YoY); FY22 record revenue $859M.","GAAP EPS $0.32; non-GAAP EPS $0.42 diluted (FY22: $0.73 GAAP, $1.43 non-GAAP).","Operating cash flow $17M; cash & securities $113M at year-end.","Q1 FY2023 guidance: revenue $195M-$215M, non-GAAP EPS $0.10-$0.30.","Medical flat YoY, Industrial +9% YoY; supply chain improving."],"consensus_eps_estimate":null,"consensus_eps_actual":0.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":859400000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355409,"accession_number":"0001681622-22-000077","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K/A","filed_at":"2022-08-19T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Varex appoints Kathleen Bardwell to Board, Audit Committee, and Comp Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kathleen L. Bardwell appointed to Board effective July 29, 2022, term expires at 2023 annual meeting.","On August 18, 2022, Bardwell appointed to Audit Committee and Compensation and Human Capital Management Committee.","Board determined Bardwell qualifies as audit committee financial expert under Reg S-K Item 407(d)(5)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":355410,"accession_number":"0001681622-22-000061","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2022-08-02T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Varex reports Q3 FY2022 revenue $214M, GAAP EPS $0.20; board adds Kathleen Bardwell","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $214M, flat QoQ and +2% YoY; Medical segment flat, Industrial +8% YoY.","GAAP diluted EPS $0.20; non-GAAP diluted EPS $0.37; non-GAAP gross margin 35%.","Q4 FY2022 guidance: revenue $210M-$240M, non-GAAP EPS $0.25-$0.45.","Board appointed Kathleen L. Bardwell, former STERIS SVP Regulatory Affairs & Compliance, effective July 29, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":628000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":373573,"accession_number":"0001681622-22-000047","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2022-05-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q2 FY2022 revenue $215M, non-GAAP EPS $0.37; guides Q3 revenue $190-220M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $215M, +8% sequentially and +6% YoY; Medical segment +9% YoY, Industrial -6% YoY.","GAAP EPS $0.18; non-GAAP EPS $0.37, up from $0.25 in prior quarter.","Cash from operations -$8M; cash down $43M to $115M after $27M note redemption.","Q3 FY2022 guidance: revenue $190-220M, non-GAAP EPS $0.10-0.30."],"consensus_eps_estimate":null,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":413500000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392264,"accession_number":"0001681622-22-000032","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2022-02-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Varex stockholders elect seven directors, approve advisory say-on-pay, ESPP amendment, and auditor ratification","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected with strong support; broker non-votes ~2.16M.","Advisory vote on executive compensation passed with 94.6% of votes cast in favor.","Amendment to 2017 Employee Stock Purchase Plan approved overwhelmingly (99.9% of votes cast).","Ratification of Deloitte & Touche as auditor for FY2022 approved with 99.8% of votes cast."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392263,"accession_number":"0001681622-22-000009","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2022-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q1 FY2022 revenue $199M below expectations; non-GAAP EPS $0.25; guides Q2 revenue $190-220M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $199M (+12% YoY, -12% sequential); GAAP EPS $0.03; non-GAAP EPS $0.25.","Medical segment revenue +12% YoY; Industrial +14% YoY; supply chain constraints limited order fulfillment.","Cash and equivalents $158M (+$13M QoQ); operating cash flow $11M.","Q2 FY2022 guidance: revenue $190-220M; non-GAAP EPS $0.15-$0.40.","Gross margin: GAAP 33%, non-GAAP 34%; operating expense control drove profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":198800000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410584,"accession_number":"0001681622-21-000097","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2021-11-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex reports record Q4 revenue $226M; Non-GAAP EPS $0.45; guides Q1 FY22 rev $200-220M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 FY21 revenue $226M (record), up 7% sequentially and 33% YoY; Non-GAAP EPS $0.45 vs GAAP $0.20.","FY21 revenue $818M, Non-GAAP EPS $1.31 vs GAAP $0.43; gross margin 33% GAAP, 35% Non-GAAP.","Q1 FY22 guidance: revenue $200-220M, Non-GAAP EPS $0.20-0.40.","Q4 cash from operations $51M; cash and equivalents $145M; completed $30M bond redemption during quarter.","Strong demand in Medical and Industrial segments amid supply chain challenges."],"consensus_eps_estimate":null,"consensus_eps_actual":0.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":818100000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":429390,"accession_number":"0001681622-21-000083","cik":1681622,"company_name":"Varex Imaging Corp","ticker":"VREX","form_type":"8-K","filed_at":"2021-08-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Varex Q3 FY21 revenue $211M (+23% YoY, +4% seq); Non-GAAP EPS $0.40","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $211M, up 23% YoY and 4% sequentially, driven by Medical and Industrial segment demand.","GAAP EPS $0.29, Non-GAAP EPS $0.40; Non-GAAP gross margin 36%, up on higher volume and productivity.","Cash from operations $22M; cash balance $128M (+$17M seq). $30M partial redemption of 7.875% senior secured notes post quarter.","Q4 FY21 guidance: revenue $205M-$225M, Non-GAAP EPS $0.25-$0.40."],"consensus_eps_estimate":null,"consensus_eps_actual":0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":591800000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":392370000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}